Tag: genomics
-
Late-Stage Covid-19 Vaccine Trial Underway in U.S.
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes.
-
Engineered Mosquitoes Approved for Disease Control
In an apparent end to a long-running dispute, authorities in the Florida Keys approved a field trial of engineered mosquitoes to control tropical diseases.
-
Women’s Heart Health Diagnostics in the Works
An organization for redressing health disparities faced by women awarded a new grant to advance better tools for predicting risk of women’s heart disease.
-
Start-Up Developing Microbial Cancer Detection Tests
A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples.
-
Hospitals Testing Fast Covid-19 Diagnostic
A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that returns results in about an hour.
-
Giant Hornet Genome Sequenced
The genome of the Asian giant hornet, a species threatening bees and humans, was analyzed, with the data released by the Agricultural Research Service.
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Trial Underway for Seasonal Flu Antibody Therapy
A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza.
-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.